PLUS1
Azure Healthcare Financial Data
| Company name: | Azure Healthcare Ltd | Status: | Active |
| End of fiscal year: | 2018年6月30日 | ISIN | AU000000AZV6 |
| Year established: | 2004 | Company sector name: | Healthcare |
| Trading currency: | AUD | Industry name: | Medical Devices |
| Place of incorporation: | Australia (AU) | Industry group name | Medical Devices |
| Doing business in: | Australia (AU) | Address | 31 Sabre Drive Unit 1, 3207 |
| Tel.: | +61 392099688 | City/Country: | Melbourne, Australia |
| Fax: | +61 392099699 | Web address: | http://www.azurehealthcare.com.au |
| Company description: | Azure Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patients; and CellGuard that provides audio communication solution, including officer duress, cell intercom, discrete monitoring, door intercom, background music distribution, and public address announcements. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America. The company generates maximum revenue from Australia/New Zealand. |
| 現在 | 前日比 [%] | ビッド | オファー | 始値 | 高値 | 安値 | 数量 |
|---|---|---|---|---|---|---|---|
| 0.091 | 0.00[0.0%] | 0.091 | 0.095 | 0.00 | |||
| 時価総額 [百万] | 発行済株式数 [百万] | Beta | EPS | DPS | PER | 利回り | 52週レンジ |
| 232.712826 | - - - |
AZV Balance Sheet Chart (-) | ||
|---|---|---|
 | ||
| 期間 † | 高値 | 安値 |
|---|---|---|
| 1週 | 0.00 | 0.00 |
| 1ヶ月 | 0.00 | 0.00 |
| 3ヶ月 | 0.00 | 0.00 |
| 6ヶ月 | 0.00 | 0.00 |
| 1年 | 0.00 | 0.00 |
| 3年 | 0.125 | 0.048 |
| 5年 | 0.125 | 0.048 |
Share price performance previous 3 years |
|---|
Share price performance intraday |
|---|
| 期間 † | 始値 | 平均始値 | VWAP | 最小出来高 | 最大出来高 | 平均出来高 | 前日比 | % |
|---|---|---|---|---|---|---|---|---|
| 1週 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 1ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 3ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 6ヶ月 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 1年 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 3年 | 0.09 | 0.080043 | 0.078147 | 354 | 2,845,405 | 262,626 | 0.001 | 1.11% |
| 5年 | 0.065 | 0.076186 | 0.076897 | 4 | 2,845,405 | 168,253 | 0.026 | 40.0% |
AZV Growth Ratios (-) | ||||
|---|---|---|---|---|
| 1 year | 3 years | 5 years | 10 years | |
Diluted EPS growth | - | - | - | - |
Diluted continuous EPS growth | - | - | - | - |
Dividend growth | - | - | - | - |
Equity per share growth | - | - | - | - |
Revenue growth | - | - | - | - |
Operating income growth | - | - | - | - |
Net income growth | - | - | - | - |
Net income cont growth | - | - | - | - |
CFO growth | - | - | - | - |
FCF growth | - | - | - | - |
Operating revenue growth | - | - | - | - |
AZV Efficency Ratios (-) | |
|---|---|
Days in sales | - |
Days in inventory | - |
Days in payment | - |
Cash conversion cycle | - |
Receivable turnover | - |
Inventory turnover | - |
Payable turnover | - |
Fixed assets turnover | - |
Assets turnover | - |
ROE | - |
ROA | - |
ROIC | - |
FCF sales ratio | - |
FCF net income ratio | - |
Capital expenditure sales ratio | - |
AZV Financial Health Ratios (-) | |
|---|---|
Current ratio | - |
Quick ratio | - |
Debt total capital ratio | - |
Debt equity ratio | - |
Financial leverage | - |
Total debt to equity | - |
AZV Avearge Growth Ratios Over 5 Years (-) | |
|---|---|
Growth ann capital spending | - |
Growth ann gross profit | - |
Avg gross margin | - |
Avg post tax margin | - |
Avg pre tax marginr | - |
Avg net profit | - |
Avg ret commonr | - |
Avg ret assets | - |
Avg ret invested capital | - |
AZV Profitability Ratios (-) | |
|---|---|
Gross margin | - |
Operating margin | - |
EBT margin | - |
Tax rate | - |
Net margin | - |
Sales per employee | - |
EBIT margin | - |
EBITDA margin | - |
Normalized net profit margin | - |
Interest coverage | - |
Inc per employee tot ops | - |
AZV Valuation Ratios (-) | |
|---|---|
Sales per share | - |
Growth ann sales per share 5 ye... | - |
Book value per share | - |
CF per share | - |
Price to EPS | - |
Ratio PE 5 year high | - |
Ratio PE 5 year low | - |
Price to book | - |
Price to sales | - |
Price to cash flow | - |
Price to free cash flow | - |
Div rate | - |
Dividend yield | - |
Div payout tot ops | - |
Div payout 5 year | - |
Payout ratio | - |
Sustainable growth rate | - |
Cash return | - |